Servicios Personalizados
Revista
Articulo
Español (pdf)
Artículo en XML
Referencias del artículo
Traducción automática
Enviar artículo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Similares en
SciELO
Compartir
Permalink
Acta ortopédica mexicana
versión impresa ISSN 2306-4102
Resumen
GUERRERO-MOLINA, AL; CRUZ-ALVAREZ, MG y TENOPALA-VILLEGAS, S. Bibliographic review of the efficacy of platelet-rich plasma treatment in lumbar disc herniation. Acta ortop. mex [online]. 2023, vol.37, n.5, pp.290-295. Epub 09-Sep-2024. ISSN 2306-4102. https://doi.org/10.35366/113963.
Platelet-rich plasma (PRP) is an autologous blood product containing growth factors and proteins, widely employed in the clinical setting for tissue repair. Robust evidence in basic science literature has facilitated clinical research involving PRP for patients with disc disease and lumbar pain. Degenerative disc disease (DDD) has been identified as a significant contributor to lower back pain, with approximately 40% of patients under 30 and 90% of those over 50 experiencing lumbar pain showing MRI findings consistent with degenerative changes in intervertebral discs. Regenerative medicine within the disc has primarily been studied in patients with chronic, untreatable lumbar pain.
Objective:
to understand the available evidence regarding the efficacy of PRP in lumbar disc herniation. By understanding the scientific evidence supporting PRP as a lumbar disc herniation treatment, a research project can be developed, providing the theoretical foundation for implementing this therapy in the Mexican population. A search was conducted using PUBMED, ClinicalKey (Elsevier), Medscape, Science Direct, and Google Scholar databases.
Conclusions:
despite promising results in several studies on intradiscal PRP injection, small sample sizes and non-standardized graft preparation procedures have hindered these research efforts.
Palabras llave : plasma; PRP; herniated disc; regenerative medicine; pain.
